Dr. Farkouh is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5 E 98th St
3rd Floor
New York, NY 10029Phone+1 212-241-5586
Education & Training
- Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalFellowship, Cardiovascular Disease, 1996 - 1998
- Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 1989 - 1992
- University of Western OntarioClass of 1988
Certifications & Licensure
- NY State Medical License 2009 - 2018
Awards, Honors, & Recognition
- Fellow (FACC) American College of Cardiology
Clinical Trials
- Comparison of Two Treatments for Multivessel Coronary Artery Disease in Individuals With Diabetes (FREEDOM) Start of enrollment: 2004 Apr 01
- Using Big Data to Conduct Innovative Cardiovascular Clinical Trials Start of enrollment: 2019 Oct 01
- The Açaí Berry COVID-19 Anti-Inflammation Trial Start of enrollment: 2020 Aug 04
Publications & Presentations
PubMed
- 342 citationsAssociation between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis.Jacob A. Udell, Rami Zawi, Deepak L. Bhatt, Maryam Keshtkar-Jahromi, Fiona Gaughran
JAMA. 2013-10-23 - 37 citationsStatins and contrast-induced acute kidney injury with coronary angiography.Sumeet Gandhi, Wassim Mosleh, Husam Abdel-Qadir, Michael E. Farkouh
The American Journal of Medicine. 2014-10-01 - 351 citationsInflammation, Immunity, and Infection in Atherothrombosis: JACC Review Topic of the Week.Peter Libby, Joseph Loscalzo, Paul M. Ridker, Michael E. Farkouh, Priscilla Y. Hsue
Journal of the American College of Cardiology. 2018-10-23
Journal Articles
- Moving Beyond the StentMichael Farkouh, MD, JACC: Cardiovascular Imaging
Authored Content
- Effect of Genotype-Guided Oral P2Y12 Inhibitor Selection vs Conventional Clopidogrel Therapy on Ischemic Outcomes After Percutaneous Coronary InterventionAugust 2020
- Effect of Genotype-Guided Oral P2Y12 Inhibitor Selection vs Conventional Clopidogrel Therapy on Ischemic Outcomes After Percutaneous Coronary InterventionAugust 2020
- Prevention of Heart Failure with SGLT-2 Inhibition Insights from CVD-REALMay 2018
- Prevention of Heart Failure with SGLT-2 Inhibition Insights from CVD-REALMay 2018
- Join now to see all
Press Mentions
- Cedars-Sinai Taps Renowned Cardiologist as Associate Dean of Clinical TrialsJanuary 19th, 2023
- Michael E. Farkouh, MD, MSc, Named Associate Dean for Research and Clinical TrialsJanuary 17th, 2023
- Polypill Along with Aspirin Cuts Heart Attacks and Strokes by up to 40%: International StudyNovember 12th, 2020
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: